Related Experiment Videos

Immunomodulatory activities of Nocardia opaca

J K Tomecki1, K Cieślik, A M Kordowiak

  • 1Department of Microbiology and Immunology, Institute of Molecular Biology Jagiellonian University, Cracow, Poland.

Acta Microbiologica Polonica
|January 1, 1993
PubMed

Insights

Nocardia lysozyme digest (NLD) shows antitumor effects against lung sarcoma in mice. NLD immunotherapy inhibited tumor growth and improved survival by modulating immune responses.

Area of Science:

  • Immunology
  • Oncology
  • Microbiology

Background:

  • Nocardia lysozyme digest (NLD), derived from Nocardia opaca, is a potential immunomodulator.
  • Tumor immunotherapy remains a critical area in cancer research.

Purpose of the Study:

  • To investigate the antitumor activity of Nocardia lysozyme digest (NLD).
  • To evaluate the immunomodulatory effects of NLD in a murine lung sarcoma model.

Main Methods:

  • Induction of SaL-1 lung sarcoma in Balb/c mice.
  • Administration of Nocardia lysozyme digest (NLD) for immunization.
  • Analysis of tumor growth, animal survival, and macrophage responses.

Main Results:

  • NLD immunization inhibited tumor growth and prolonged survival in tumor-bearing mice.
  • Macrophages stimulated with NLD released arachidonic acid metabolites, primarily PGE2.
  • Macrophages from tumor-bearing mice exhibited increased sensitivity to Nocardia antigens.

Conclusions:

  • Nocardia lysozyme digest (NLD) demonstrates significant antitumor activity.
  • Nocardia acts as an effective immunomodulator, impacting macrophage function in vivo and in vitro.

Related Concept Videos